Mergers & Acquisitions - Biotechnology, Johnson & Johnson


Popular Filters

News briefs from Alimera on Iluvien and Xencor on Xtend; Galapagos milestone and acquisition


US biopharma company Alimera Sciences (Nasdaq: ALIM) says that the Spanish Agency of Drugs and Medical…

Alimera SciencesBiotechnologyCangenixGalapagosIluvienJanssenJohnson & JohnsonMergers & AcquisitionsOphthalmicsPharmaceuticalRegulationResearchXencorXtend

J&J's Janssen files Xarelto with FDA for new indication; buys Chinese firm


US health care major Johnson & Johnson's (NYSE: JNJ) subsidiary Janssen Research & Development says it…

Asia-PacificBayerBioseal BiotechBiotechnologyCardio-vascularJanssenJohnson & JohnsonMergers & AcquisitionsNorth AmericaPharmaceuticalRegulationXarelto

Back to top